Metagenomi, Inc. (NASDAQ: MGX) reported Q2 EPS of ($0.54), $0.18 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $8.51 million.

For earnings history and earnings-related data on Metagenomi, Inc. (MGX) click here.